N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α/HO-1 Signaling in Diabetic Rats

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Mao, Xiaowen ^a   Wang, Tingting ^a   Liu, Yanan ^a   Irwin, Michael G ^a   Ou, Jing song ^b   Liao, Xiao long ^b   Gao, Xia ^c   Xu, Yuan ^c   Ng, Kwok F J ^a,b   Vanhoutte, Paul M ^a   Xia, Zhengyuan ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ACETYLCYSTEINE; ALLOPURINOL; HEME OXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOPROSTANE DERIVATIVE; LACTATE DEHYDROGENASE; PROTOPORPHYRIN TIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; IN VIVO STUDY; LOW DRUG DOSE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION;

EID: 84880401475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068949     Document Type: Article

References (60)

1. Buja LM, (2005) Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 14: 170-175.
2. Alserius T, Hammar N, Nordqvist T, Ivert T, (2006) Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J 152: 599-605.
3. Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, et al. (2003) Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125: 144-154.
4. Rolo AP, Palmeira CM, (2006) Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 212: 167-178.
5. Bao W, Qin P, Needle S, Erickson-Miller CL, Duffy KJ, et al. (2010) Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J Cardiovasc Pharmacol 56: 147-155.
6. Laderoute KR, (2005) The interaction between HIF-1 and AP-1 transcription factors in response to low oxygen. Semin Cell Dev Biol 16: 502-513.
7. Maxwell PH, (2005) Hypoxia-inducible factor as a physiological regulator. Exp Physiol 90: 791-797.
8. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, et al. (2002) Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45: 1172-1181.
9. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, et al. (2004) Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 53: 2383-2391.
10. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, et al. (2005) HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American journal of physiology Heart and circulatory physiology 289: H542-548.
11. Bak I, Papp G, Turoczi T, Varga E, Szendrei L, et al. (2002) The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 33: 639-648.
12. Bak I, Szendrei L, Turoczi T, Papp G, Joo F, et al. (2003) Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J 17: 2133-2135.
13. Bak I, Czompa A, Juhasz B, Lekli I, Tosaki A (2010) Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts*. J Cell Mol Med.
14. Juhasz B, Varga B, Czompa A, Bak I, Lekli I, et al. (2011) Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium. J Cell Mol Med 15: 1973-1982.
15. Otterbein LE, Choi AM, (2000) Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029-1037.
16. Takahashi T, Shimizu H, Akagi R, Morita K, Sassa S, (2006) Heme oxygenase-1: A new drug target in oxidative tissue injuries in critically ill conditions. Drug Development Research 67: 130-153.
17. Di Filippo C, Marfella R, Cuzzocrea S, Piegari E, Petronella P, et al. (2005) Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 54: 803-810.
18. Semenza GL, (2011) Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 1813: 1263-1268.
19. Xin XY, Pan J, Wang XQ, Ma JF, Ding JQ, et al. (2011) 2-methoxyestradiol attenuates autophagy activation after global ischemia. Can J Neurol Sci 38: 631-638.
20. Sadi G, Guray T, (2009) Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: effect of antioxidants. Mol Cell Biochem 327: 127-134.
21. Bento CF, Pereira P, (2011) Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes. Diabetologia 54: 1946-1956.
22. Wang T, Qiao S, Lei S, Liu Y, Ng KF, et al. (2011) N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One 6: e23967.
23. Huang ZY, Xia ZY, Ansley DM, Dhaliwal BS, (2004) [Clinical significance of plasma free 15-F2t-isoprostane concentration during coronary artery bypasses graft surgery]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16: 165-168.
24. Xue W, Liu Y, Zhao J, Cai L, Li X, et al. (2012) Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. Am J Physiol Heart Circ Physiol 302: H2528-2535.
25. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, et al. (2004) Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37: 959-968.
26. Xiao J, She Q, Wang Y, Luo K, Yin Y, et al. (2009) Effect of allopurinol on cardiomyocyte apoptosis in rats after myocardial infarction. Eur J Heart Fail 11: 20-27.
27. Guo ZX, Xia ZY, Jiang JH, McNeill JH, (2007) Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. American Journal of Physiology-Heart and Circulatory Physiology 292: H1728-H1736.
28. Desco MC, Asensi A, Marquez R, Martinez-Valls J, Vento M, et al. (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes- Protection by allopurinol. Diabetes 51: 1118-1124.
29. Tsai GY, Cui JZ, Syed H, Xia Z, Ozerdem U, et al. (2009) Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats. Clin Experiment Ophthalmol 37: 223-231.
30. Karwinski W, Garcia R, Helton WS, (1994) Allopurinol dose is important for attenuation of liver dysfunction after normothermic ischemia: correlation between bile flow and liver enzymes in circulation. Res Exp Med (Berl) 194: 321-327.
31. Gao X, Xu Y, Xu B, Liu Y, Cai J, et al. (2012) Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes. Diabetes Metab Res Rev 28: 409-417.
32. Zhou D, Matchett GA, Jadhav V, Dach N, Zhang JH, (2008) The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats. Neurol Res 30: 268-271.
33. Hangaishi M, Ishizaka N, Aizawa T, Kurihara Y, Taguchi J, et al. (2000) Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 279: 582-588.
34. Liu Y, Lei S, Gao X, Mao X, Wang T, et al. (2012) PKCbeta inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin Sci (Lond) 122: 161-173.
35. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, et al. (2011) Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci (Lond) 120: 251-261.
36. Huang ZY, Zhong XW, Irwin MG, Ji SY, Wong GT, et al. (2011) Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clinical Science 121: 57-69.
37. Dai Y, Xu M, Wang Y, Pasha Z, Li T, et al. (2007) HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42: 1036-1044.
38. Kaga S, Zhan LJ, Matsumoto M, Maulik N, (2005) Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39: 813-822.
39. Kumar S, Sitasawad SL, (2009) N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. Life Sci 84: 328-336.
40. Dhiman M, Garg NJ, (2011) NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease. J Pathol 225: 583-596.
41. Damnicki-Abegg M, Weihrauch D, Chiari PC, Krolikowski JG, Pagel PS, et al. (2007) Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-i expression and cardioprotection. J Cardiovasc Pharmacol 50: 670-676.
42. Wang B, Ouyang J, Xia Z, (2006) Effects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expression. Can J Physiol Pharmacol 84: 935-941.
43. Xu B, Gao X, Xu J, Lei S, Xia ZY, et al. (2011) Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J Surg Res 166: e157-164.
44. Lei S, Li H, Xu J, Liu Y, Gao X, et al. (2013) Hyperglycemia-induced PKCbeta2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS Signaling. Diabetes.
45. Turer AT, Mahaffey KW, Gallup D, Weaver WD, Christenson RH, et al. (2005) Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med 6: 12.
46. Christenson RH, Vollmer RT, Ohman EM, Peck S, Thompson TD, et al. (2000) Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol 85: 543-547.
47. Xia Z, Kuo KH, Godin DV, Walker MJ, Tao MC, et al. (2005) 15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts. Am J Physiol Heart Circ Physiol 289: H1366-1372.
48. Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, et al. (2008) Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 233: 84-93.
49. Duda M, Konior A, Klemenska E, Beresewicz A, (2007) Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J Mol Cell Cardiol 42: 400-410.
50. Kusmic C, Basta G, Lazzerini G, Vesentini N, Barsacchi R, (2004) The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart: a link between vitamin E preservation and prostaglandin biosynthesis. J Cardiovasc Pharmacol 44: 356-362.
51. Tosaki A, Pali T, Droy-Lefaix MT, (1996) Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 39: 1255-1262.
52. Nie R, Xia R, Zhong X, Xia Z, (2007) Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat. Can J Physiol Pharmacol 85: 1012-1019.
53. Xia Z, Godin DV, Ansley DM, (2004) Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Can J Physiol Pharmacol 82: 919-926.
54. Ferrari R, Alfieri O, Curello S, Ceconi C, Cargnoni A, et al. (1990) Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81: 201-211.
55. Boueiz A, Damarla M, Hassoun PM, (2008) Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol 294: L830-840.
56. Oliveira PJ, Goncalves L, Monteiro P, Providencia LA, Moreno AJ, (2005) Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria? Curr Vasc Pharmacol 3: 147-158.
57. Sloan RC, Moukdar F, Frasier CR, Patel HD, Bostian PA, et al. (2012) Mitochondrial permeability transition in the diabetic heart: Contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury. J Mol Cell Cardiol 52: 1009-1018.
58. Rajesh M, Mukhopadhyay P, Batkai S, Mukhopadhyay B, Patel V, et al. (2009) Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 13: 2330-2341.
59. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
60. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, et al. (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108: 79-85.